Removing prescriber and pharmacist restrictions has expanded pharmacy access to MS-2 Step, but regional gaps remain.
Cannabis-related hospital admissions in Victoria rose by almost half in a decade, with psychosis the leading cause, new research found.
Around 1.9 million Australians were regularly dispensed five or more medicines at the same time in 2025, according to the first report on polypharmacy ever published by the Australian Institute of Health and Welfare (AIHW).
A new synthetic opioid, cychlorphine, is spreading through illicit drug markets in Europe and North America.
Cardiovascular disease is increasingly preventable and treatable – but too many Australians are still being missed. From identifying hypertension earlier to navigating new medicines, community pharmacists can help to improve cardiovascular care.
Several regulatory, funding and accreditation changes will land on 1 October 2026. AP breaks down what pharmacists need to know.
COVID-19 vaccines will move onto the National Immunisation Program later this week. Who is now eligible for a funded vaccine and what should pharmacists tell patients who aren’t?
The TGA has removed Andrographis from the listed medicines framework. Here’s what pharmacists need to know about affected products, product recalls and patient counselling.
As ADHD medicine use surges and prescribing pathways evolve, pharmacists are increasingly acting as a clinical safety net and health system navigator.
Pharmacists across Australia can access thousands in government funding to complete PSA’s Graduate Certificate in Pharmacist Prescribing.
